Both in Biotechnology
Vir Biotechnology vs Replimune Group
Over the past year VIR returned +100.4% and REPL returned +121.9%; their daily moves had a correlation of 0.17.
VIR +100.4% REPL +121.9%Growth of $1, one year, split-adjusted
| Metric | VIR | REPL |
|---|---|---|
| Price | $11.22 | $20.65 |
| Market cap | $1.90B | $1.96B |
| Today | +2.00% | +5.95% |
| 1 month | −4.8% | +57.0% |
| 6 months | +12.1% | +619.5% |
| Year to date | +86.1% | +112.4% |
| 1 year | +88.3% | — |
| Revenue growth (YoY) | +19582.5% | — |
| Gross margin | 100.0% | — |
| Net margin | 33.5% | — |
| P/E (TTM) | — | — |
| Price / sales | 6.3× | — |
| Net cash | $532.7M | $183.7M |
| Dividend yield | — | — |
| Volatility (60d) | 51.5% | 77.7% |
| Short % of float | 12.3% | 29.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).